NCT05863741

Brief Summary

This study titled "Does Personalised Soft Tissue Balance Data Improve Outcomes in Patients Undergoing Medially Stabilised Arthroplasty? A Prospective, Randomised Study Investigating the Clinical Utility of the NextAR navigation system (NextAR)" is a randomised, single blinded, prospective cohort study with the primary aim determine the clinical utility of the NextAR system data in providing soft tissue balance patterns to enable prosthesis implants to resemble more native knee alignment.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started May 2022

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 15, 2022

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

April 26, 2023

Completed
22 days until next milestone

First Posted

Study publicly available on registry

May 18, 2023

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 12, 2025

Completed
12 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2026

Completed
Last Updated

September 29, 2025

Status Verified

September 1, 2025

Enrollment Period

3 years

First QC Date

April 26, 2023

Last Update Submit

September 23, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Determine whether NextAR system data contributes to change patient outcomes using the Forgotten Joint Score

    To determine whether NextAR system data contributes to change patient outcomes using the Forgotten Joint Score \- Forgotten Joint Score measures the patient's ability to forget about the joint as a result of successful treatment and is based on the premise that the best arthroplasty is one the patient forgets. This score goes from a minimum of 0 to a maximum of 100 points.

    pre-op, 6 weeks, 6 months, 1 year, 2 years

Secondary Outcomes (4)

  • To determine whether NextAR system data contributes to change patient outcomes using the EQ5D-5L

    pre-op, 6 weeks, 6 months, 1 year, 2 years

  • Determining the kinematics of the replaced knee as measured by 3D gait analysis.

    pre-op, 1 year

  • To determine whether NextAR system data contributes to change patient outcomes using the Oxford Knee Score

    pre-op, 6 weeks, 6 months, 1 year, 2 years

  • To determine whether NextAR system data contributes to change patient outcomes using the Forgotten Joint Score using the International Knee Documentation Committee

    pre-op, 6 weeks, 6 months, 1 year, 2 years

Study Arms (2)

control study

patients will be operated with conventional instrumentation

Device: Implantation of GMK Sphere with conventional instrumentation

NextAR study

patients will be operated using the NextAR guidance system

Device: Implantation of GMK Sphere using the NextAR guidance system

Interventions

Implantation of GMK Sphere with conventional instrumentation (control group)

control study

Implantation of GMK Sphere using the NextAR guidance system (NextAR group)

NextAR study

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

The trial will include two groups of 50 patients in each group. This is based on a power calculation assuming a difference in Forgotten Join Score of greater than 5 points. This calculation allows for a loss to follow-up of 10%. The study will conclude once the patients involved have completed 2 years of follow-up.

You may qualify if:

  • End-stage osteoarthritis of the knee suitable for total knee arthroplasty.
  • Aged over 18 years.

You may not qualify if:

  • Unsuitable for TKR due to chronic infection, medical disease, inability to consent, inability to attend for post-operative follow-up, significant psychiatric issues, substance abuse issues
  • Previous reconstructive/fracture/arthroplasty surgery on affected knee
  • Active inflammation arthropathy
  • Significant extra articular deformity
  • Morbidly Obese (BMI \>40)
  • Pregnant women

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fremantle Hospital

Fremantle, Australia

RECRUITING

Study Officials

  • Ben Jeffcote

    Fremantle Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 26, 2023

First Posted

May 18, 2023

Study Start

May 15, 2022

Primary Completion

May 12, 2025

Study Completion

May 1, 2026

Last Updated

September 29, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations